Literature DB >> 29410104

Evaluation of a novel optical assay for rapid detection of methicillin-resistant Staphylococcus aureus in liquid culture.

Dennis Knaack1, Evgeny A Idelevich2, Barbara Körber-Irrgang3, Michael Kresken4, Karsten Becker2.   

Abstract

Valid detection of methicillin-resistant Staphylococcus aureus (MRSA) is a precondition for MRSA prevention measures. Most of the available MRSA screening tests are based either on the identification of colony material grown on solid agar media or on direct molecular approaches. The HB&L MRSA KIT (Alifax, Polverara, Italy) is designed to screen for MRSA in liquid cultures applying the light scattering technology. Here, the assay was evaluated with pure culture isolates from solid agar media on a representative subset of 29 MRSA and 171 methicillin-susceptible S. aureus clinical strains from a German multicenter study reflecting the ratio of MRSA to MSSA in Germany. Additionally, 53 mecA/mecC-MRSA comprising hospital-, community and livestock-associated MRSA as well as 20 clinical coagulase-negative staphylococci (CoNS) challenge strains were tested. Including the results of the assay-immanent confirmatory tests for positively tested strains, the sensitivity, specificity and the positive and negative predictive values were 100%. The methicillin-resistance was also correctly identified for all challenge strains.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial susceptibility testing; Light scattering technology; MRSA; Rapid testing; Screening

Mesh:

Substances:

Year:  2018        PMID: 29410104     DOI: 10.1016/j.mimet.2018.01.016

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  1 in total

1.  Evaluation of two rapid phenotypical tests-Alifax rapid AST colistin test and Rapid Polymyxin NP test-for detection of colistin resistance in Enterobacterales.

Authors:  Julija Germ; Katja Seme; Tjasa Cerar; Veronika Krizan Hergouth; Mateja Pirs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-02-17       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.